Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2008–2029 · program · P50
Developmental Research Program (DRP)
Juan Fueyo · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2008–2024 · program · P50
Pathology and Biorepository Core (Core B)
Jason Huse · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2008–2029 · program · P50
Project 1: Combine Viro-Immunotherapy and Natural Killer Cells for the Treatment of Gliomas
Juan Fueyo · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2008–2029 · program · P50
Biostatistics and Bioinformatics Core (Core C)
Ying Yuan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2008–2024 · program · P50
Animal Core (Core D)
Betty Kim · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2008–2024 · program · P50
Developmental Research Program (DRP)
Juan Fueyo · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2007–2026 · research · R01
Gene-Product Auto-Targeting to Tumor Vessels
Shulin Li · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2007–2020 · research · R01
Gene-Product Auto-Targeting to Tumor Vessels
Shulin Li · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2007–2026 · research · R01
Gene-Product Auto-Targeting to Tumor Vessels
Shulin Li · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2006–2020 · research · R37
Regulation of T-cell function and autoimmune inflammation by deubiquitinases.
Shao-Cong Sun · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2006–2021 · program · P01
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
Ronald Anthony Depinho · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2006–2020 · research · R37
Regulation of T-cell function and autoimmune inflammation by deubiquitinases.
Shao-Cong Sun · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2006–2020 · research · R37
Regulation of T-cell function and autoimmune inflammation by deubiquitinases.
Shao-Cong Sun · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2006–2021 · program · P01
Project 3: The Functional Contribution of Tumor Immunity in PDAC
Raghu Kalluri · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2006–2021 · program · P01
Program Integration and Management
Ronald Anthony Depinho · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2006–2021 · program · P01
Core B: Preclinical Therapeutics Core
Cyril Henri Benes · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2006–2021 · program · P01
Project 1: Targeting Metabolic Dependencies in PDAC
Ronald Anthony Depinho · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2005–2026 · program · P01
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
Ronald Anthony Depinho · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2005–2026 · program · P01
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
Ronald Anthony Depinho · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2005–2026 · program · P01
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
Ronald Anthony Depinho · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2005–2026 · training · T32
Training of Academic Gynecologic Oncologists
Michael Frumovitz · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2005–2021 · training · T32
Training of Academic Gynecologic Oncologists
Karen Hsieh Lu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2005–2021 · training · T32
Training of Academic Gynecologic Oncologists
Karen Hsieh Lu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2005–2026 · program · P01
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
Ronald Anthony Depinho · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2005–2026 · training · T32
Training of Academic Gynecologic Oncologists
Michael Frumovitz · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2005–2026 · training · T32
Training of Academic Gynecologic Oncologists
Kathleen Schmeler · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2005–2021 · program · P01
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
Ronald Anthony Depinho · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2005–2026 · program · P01
Core C-Computational Core
Phillip Andrew Futreal · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2005–2026 · program · P01
Project 2-Identifying and exploiting metabolic vulnerabilities in PDAC
Nabeel El-Bardeesy · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2005–2026 · program · P01
Core D- Administrative Core
Ronald Anthony Depinho · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2005–2026 · program · P01
Core A-Pathology Core
Huamin Wang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2005–2026 · program · P01
Core B-Modeling & Experimental Therapeutics Core
James Wesley Horner · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2005–2026 · program · P01
Core B-Modeling & Experimental Therapeutics Core
James Wesley Horner · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2005–2026 · program · P01
Project 1- Elucidating oncogenic KRAS in PDAC cell signaling, resistance and immunity
Ronald Anthony Depinho · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2005–2026 · program · P01
Project 3-Cancer cell interaction with oncogenic type 1 collagen in PDAC
Raghu Kalluri · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2005–2026 · program · P01
Project 1- Elucidating oncogenic KRAS in PDAC cell signaling, resistance and immunity
Ronald Anthony Depinho · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2004–2020 · research · R01
Molecular Mechanisms Regulating TLR Signaling and Macrophage Activation.
Shao-Cong Sun · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2004–2020 · research · R01
Regulation of Lung Cancer Metastasis by a Procollagen Lysine Hydroxylase
Jonathan M Kurie · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2004–2022 · research · R01
Molecular mechanisms regulating TLR signaling and inflammation
Shao-Cong Sun · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2004–2020 · research · R01
Molecular Mechanisms Regulating TLR Signaling and Macrophage Activation.
Shao-Cong Sun · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
